Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Fondaparinux as Postpartum VTE Prophylaxis
NCT04447378Phase 4Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Sep 2017
- Primary completion
- Jun 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of fondaparinux in venous thromboembolism (VTE), sponsored by Universiti Kebangsaan Malaysia. Started Sep 2017; status: completed.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04447378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447378.